Welcome to Procognia

 

Renowned for its world-leading position in the field of glycobiology, with special expertise in glycoanalysis, Procognia (Israel) Ltd's advanced proprietary tools provide fast, accurate and highly efficient High Throughput glycoanalysis. Procognia's unique technological platform offers a range of advantages compared to existing technologies, and is relevant to many applications, including:   
  • Process development & manufacturing of biopharmaceuticals:
    • Biosimilar
    • Innovative biological drugs
  • Life science & pharma research
  • Glycodiagnostic & biomarker methods
  • Stem cells research
  • Food ingredients and products

Procognia also offers a comprehensive, state-of-the-art solution package for process development of biosimilar drugs, from clone generation to purified bulk product for pre-clinical and clinical studies.


The company's R&D team is working intensively to continue the development of leading technologies and tools in glycobiology, based on the derivation of the glycosylation profile of proteins and to strengthen the company's contribution to biological process development for biopharmacuticals.

News&Events
25/04/2010 read more
Procognia (Israel) Ltd. and Seahorse Bioscience successfully completed the first stage in a combine study demonstrating the synergistic effect of their technologies to expand and significantly improve biopharmaceutical drugs development while reducing dramatically development cost, risks and time to market
21/01/2010 read more
Procognia has received Helsinki Committee authorization from the Tel HaShomer Medical Center to carry out a diagnostic trial focusing on colon cancer
03/12/2009 read more
Developing Antibodies for the Diagnosis and Treatment of Cancer
15/09/2009 read more
Collaboration between GP Bioscience and Procognia in the Glycodiagnostics Field